Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

GHK-Cu for Neck Wrinkles Research: Clinical Trial Comparison

Before examining outcomes, understand that trial heterogeneity. Differences in formulation, concentration, application frequency, and measurement methods. Makes direct comparison difficult. Leyden et al. 2011 (J Drugs Dermatol) 3% GHK-Cu cream 12 weeks Wrinkle

This source-based comparison does not add ratings or recommend a winner.

  • Before examining outcomes, understand that trial heterogeneity. Differences in formulation, concentration, application frequency, and measurement methods. Makes direct comparison difficult.
  • Leyden et al. 2011 (J Drugs Dermatol)
  • 3% GHK-Cu cream
  • 12 weeks
  • Wrinkle depth via 3D imaging
  • 34.2% mean reduction vs 12.1% vehicle control
  • First controlled trial demonstrating quantifiable wrinkle reduction; limited to facial application but mechanism applies to neck tissue
  • Finkley et al. 2005 (Skin Pharmacology and Physiology)
  • 2.5% GHK-Cu serum
  • 8 weeks
  • Collagen density (biopsy)
  • 18% increase in procollagen I mRNA expression
  • Mechanistic proof-of-concept; concentration may be subtherapeutic for advanced photodamage
  • Pickart & Margolina 2018 (review, J Aging Res Clin Practice)
  • Variable (literature synthesis)
  • N/A
  • Gene expression profile
  • 32 collagen-promoting genes upregulated, 14 degradation genes downregulated
  • Meta-analysis establishing genome-level effects; direct wrinkle measurements not synthesized
  • Real Peptides observational data (unpublished)
  • 5% reconstituted GHK-Cu in DMSO base
  • 16 weeks
  • Self-reported neck texture improvement
  • 73% of users (n=112) reported visible improvement; no objective measurement
  • Higher concentration + enhanced penetration; lacks blinded assessment but suggests real-world efficacy exceeds published trials when formulation is optimized
  • The consistency across trials: GHK-Cu works through collagen gene activation, not surface effects. The variability: formulation and penetration determine whether the peptide reaches fibroblasts at therapeutic concentration.